beta
CMTA
Clementia Pharmaceuticals Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Clementia Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical need.
Market Cap: 578 Million
Primary Exchange: Nasdaq Global Select
Website: http://www.clementiapharma.com
Shares Outstanding: 31.7 Million
Float: 31.7 Million
Dividend: 0.0 (0.0%)
Beta: -3.095027
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 401 trading days
From: 2017-12-22 To: 2019-02-22
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|